FDA Advisory Panel Recommends Novavax COVID-19 Vaccine for Emergency Use

An illustration picture shows vials with COVID-19 Vaccine stickers attached and syringes with the logo of U.S. biotech company Novavax, on Nov. 17, 2020. Justin Tallis/AFP via Getty Images

A U.S. Food and Drug Administration (FDA) vaccine advisory panel voted on Tuesday to recommend the emergency use of Novavax’s COVID-19 vaccine.

The advisory voted 21–0 with one abstention, after seven hours of discussion, agreeing that the benefits of a two-dose Novavax vaccine outweighed its risk for use in adults aged 18 and older.